Target intelligence / Profile preview

Ocular surface mucin

Molecular classification
Other
01

Overview

"Ocular surface/mucosa lubrication" is not a single molecular target but rather a physiological process primarily mediated by **mucins**—large glycosylated proteins secreted by goblet cells in the conjunctiva (notably MUC5AC) and membrane-associated mucins on corneal/conjunctival epithelial cells (MUC1, MUC4, MUC16)[1]. These molecules form a hydrophilic barrier that maintains tear film stability and reduces friction during blinking. Artificial tears and ophthalmic lubricants are used therapeutically to mimic or support this function in conditions like dry eye disease. The term "ocular surface/mucosa lubrication" refers broadly to this protective mechanism rather than a discrete druggable protein or receptor. **Note:** This entry is not a canonical molecular target such as an enzyme or receptor; it describes a biological process involving multiple molecules—primarily various **mucin proteins**—and should be mapped instead to specific mucin subtypes if detailed molecular targeting is required[1][2].

Other names
Ocular surface lubricationMucosal lubricationTear film mucinsOcular mucins
02

Mechanism of action

Mimic or supplement natural tear film components to reduce friction and maintain hydration[2][3] Stabilize the mucin layer and enhance adherence of aqueous layer to the ocular epithelium[1][2]

03

Biological functions

Lubrication of ocular surfaceMaintenance of tear film stabilityProtection against pathogens and debris
04

Disease associations

Dry eye disease (keratoconjunctivitis sicca)Ocular surface disorders
05

Safety considerations

Hypersensitivity reactions to additives or preservatives in artificial tears[3]Blurred vision, irritation, redness as potential side effects[3]
06

Interacting drugs

Artificial tears (various formulations)

1 more in the full profile.

Beyond the preview

Go deeper on Ocular surface mucin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface mucin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call